[SRNE] YoY Quarter Result on 31-Dec-2015 [#Q4]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
14-Mar-2016
Financial Year
2015
Quarter
31-Dec-2015 [#Q4]
Profit Trend
QoQ- -2,400.11%
YoY- -176.03%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 6,929 20,407 4,019 1,337 798 101 122 95.99%
PBT -55,746 -38,001 -12,724 -25,413 -10,207 -11,296 -3,236 60.67%
Tax -3,122 -90,424 -701 1,186 1 4 -3,090 0.17%
NP -49,776 12,425 -11,957 -23,476 -8,505 -11,296 -1,755 74.58%
Tax Rate - - - - - - - -
Total Cost 56,705 7,982 15,976 24,813 9,303 11,397 1,877 76.43%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin -718.37 60.89 -297.51 -1,755.87 -1,065.79 -11,217.68 -1,438.58 -10.92%
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
EPS -0.41 0.15 -0.23 -0.62 -0.23 -0.49 -0.14 19.60%
EPS Diluted -0.41 0.15 -0.23 -0.62 -0.23 -0.49 -0.14 19.60%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.